Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Public ClinicalTrials.gov record NCT03208387. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Biological Substrates of Impaired Neurocognitive Functioning: Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this study is to learn about the cognitive and behavioral functioning of children being treated for cancer.
Study identification
- NCT ID
- NCT03208387
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- Beery Test of Visual Motor Integration 6th edition Behavioral
- California Verbal Learning Test (CVLT-C) Behavioral
- Diffusion tensor imaging (DTI) Diagnostic Test
- Grooved Pegboard Behavioral
- MRI Diagnostic Test
- PedsQL Multidimensional Fatigue Scale Behavioral
- Resting state functional connectivity MRI (rs-fcMRI) Diagnostic Test
- Wechsler Intelligence Scale for Children - 5th edition (WISC-V) Behavioral
Behavioral · Diagnostic Test
Eligibility (public fields only)
- Age range
- 6 Years to 16 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 27, 2017
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
- Last update posted
- Jul 1, 2026
2017 – 2027
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Columbia University | New York | New York | 10032 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75235 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Brain Tumor trials
Other public records listing Brain Tumor. Sorted by last update posted; newest first. Not a recommendation.
- NCT05989893: Mapping of Human Cognition Recruiting
- NCT03972514: Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors. Active, not recruiting
- NCT07680439: Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). Not yet recruiting
- NCT05658731: Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients Recruiting
- NCT05947045: Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors Recruiting
- NCT07635329: Home-based Vision Rehabilitation Guided by Brain Imaging Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03208387, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2026 · Synced Jul 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03208387 live on ClinicalTrials.gov.